Skip to main content
Scott Smith holding machined aluminum part

When Scott Smith looks at a machine tool, he thinks not about what the powerful equipment used to shape metal can do – he’s imagining what it could do with the right added parts and strategies. As ORNL’s leader for a newly formed group, Machining and Machine Tool Research, Smith will have the opportunity to do just that.

Alex Roschli in front of BAAM

Alex Roschli is no stranger to finding himself in unique situations. After all, the early career researcher in ORNL’s Manufacturing Systems Research group bears a last name that only 29 other people share in the United States, and he’s certain he’s the only Roschli (a moniker that hails from Switzerland) with the first name Alex.

Illustration of the intricate organization of the PKA structure, wherein different parts of the protein are connected through elaborate hydrogen bonding networks (dashed yellow lines), glued together by the hydrophobic assemblies (light blue and orange volumes)—all working together to build the functional active site. Insert shows protonation of the transferred phosphoryl group (cyan mesh) and its many interactions with water and the active site amino acid residues. Credit: Jill Hemman/ORNL

OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.